Literature DB >> 7043035

The formulation of oral contraceptives: does the amount of estrogen make any clinical difference?

L Speroff.   

Abstract

Keywords:  Acceptor Characteristics; Age Factors; Biology; Blood Coagulation Effects; Cardiovascular Effects; Cerebrovascular Effects; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Methods--side effects; Diseases; Embolism; Endocrine System; Estradiol; Estrogens; Family Planning; Hematological Effects; Hemic System; Hormones; Lipid Metabolic Effects; Lipids; Oral Contraceptives, Combined; Oral Contraceptives, Low-dose; Oral Contraceptives--side effects; Physiology; Progestins, Low-dose; Smoking; Thromboembolism; Thrombosis; Vascular Diseases

Mesh:

Substances:

Year:  1982        PMID: 7043035

Source DB:  PubMed          Journal:  Johns Hopkins Med J        ISSN: 0021-7263


× No keyword cloud information.
  3 in total

1.  17beta-estradiol attenuates glycogen synthase kinase-3beta activation and tau hyperphosphorylation in Akt-independent manner.

Authors:  Hai-Rong Shi; Ling-Qiang Zhu; Shao-Hui Wang; Xin-An Liu; Qing Tian; Qi Zhang; Qun Wang; Jian-Zhi Wang
Journal:  J Neural Transm (Vienna)       Date:  2008-01-24       Impact factor: 3.575

2.  Oral contraceptive estrogen content and adverse effects.

Authors:  M Russell; S Ramcharan
Journal:  Can Fam Physician       Date:  1987-02       Impact factor: 3.275

Review 3.  Biases Inherent in Studies of Coffee Consumption in Early Pregnancy and the Risks of Subsequent Events.

Authors:  Alan Leviton
Journal:  Nutrients       Date:  2018-08-23       Impact factor: 5.717

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.